000			01763 a2200505 4500
005			20250517123841.0
264		0	_c20171120
008			201711s 0 0 eng d
022			_a1433-0431
024	7		_a10.1007/s00132-016-3352-8 _2doi
040			_aNLM _beng _cNLM
100	1		_aFígar, A
245	0	0	_aInfluence of single-dose intravenous tranexamic acid on total hip replacement : A study on transfusions, collateral complications, and readmissions. _h[electronic resource]
260			_bDer Orthopade _cApr 2017
300			_a359-365 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAged
650	0	4	_aAntifibrinolytic Agents _xadministration & dosage
650	0	4	_aArgentina _xepidemiology
650	0	4	_aArthroplasty, Replacement, Hip _xstatistics & numerical data
650	0	4	_aBlood Loss, Surgical _xprevention & control
650	0	4	_aBlood Transfusion _xstatistics & numerical data
650	0	4	_aCausality
650	0	4	_aCohort Studies
650	0	4	_aComorbidity
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aInjections, Intravenous
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPatient Readmission
650	0	4	_aPostoperative Complications _xepidemiology
650	0	4	_aPremedication _xstatistics & numerical data
650	0	4	_aPrevalence
650	0	4	_aRetrospective Studies
650	0	4	_aRisk Factors
650	0	4	_aTranexamic Acid _xadministration & dosage
650	0	4	_aTreatment Outcome
700	1		_aMc Loughlin, S
700	1		_aSlullitel, P A
700	1		_aScordo, W
700	1		_aButtaro, M A
773	0		_tDer Orthopade _gvol. 46 _gno. 4 _gp. 359-365
856	4	0	_uhttps://doi.org/10.1007/s00132-016-3352-8 _zAvailable from publisher's website
999			_c26593481 _d26593481